MedPath

F. Hoffmann-La Roche AG

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

277

Active:162
Completed:10

Trial Phases

5 Phases

Phase 1:196
Phase 2:13
Phase 3:30
+2 more phases

Drug Approvals

4

PHILIPPINES:4

Drug Approvals

Recormon

Approval Date
Jul 14, 2025
PHILIPPINES

Tecentriq

Approval Date
Jul 14, 2025
PHILIPPINES

Kadcyla

Approval Date
Jul 14, 2025
PHILIPPINES

Kadcyla

Approval Date
Jul 14, 2025
PHILIPPINES

Clinical Trials

Distribution across different clinical trial phases (248 trials with phase data)• Click on a phase to view related trials

Phase 1
196 (79.0%)
Phase 3
30 (12.1%)
Phase 2
13 (5.2%)
phase_1_2
6 (2.4%)
1 (0.4%)
Not Applicable
1 (0.4%)
Phase 4
1 (0.4%)
No trials found

News

Delhi High Court Halts Natco Pharma's Generic Risdiplam Launch in Roche Patent Dispute

The Delhi High Court has ordered Natco Pharma to maintain status quo on launching its generic version of Risdiplam, a treatment for spinal muscular atrophy, until April 2 amid Roche's patent infringement appeal.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.